10 completed, 4 unknown, 3 terminated, 2 not yet recruiting. 8 Phase 4, 6 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 3.
Follow Teicoplanin: new trials by email Literature Review of Teicoplanin trials Research Report on Teicoplanin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer | Phase 4 | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 136 | 2026-06-01 | 2026-05-15 |
| Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections. Meropenem Injection, Ceftazidime-avibactam, Teicoplanin - Acute-On-Chronic Liver Failure | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 150 | 2025-02-10 | 2025-02-10 |
| TDM-optimized Teicoplanin Dosing Versus Standard of Care Teicoplanin - Bacterial Infections | Phase 4 | Terminated | Radboud University Medical Center | 54 | 2023-08-01 | 2026-08-12 |
| Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy Sulperazon, Teicoplanin, Meropenem Injection - Cholangitis, Secondary Biliary, Treatment Compliance | Phase 4 | Completed | Tongji Hospital | 160 | 2021-05-01 | 2022-04-11 |
| Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI Xydalba, vancomycin, teicoplanin or daptomycin - Acute Bacterial Skin and Skin Structure Infection | Completed | Aziende Chimiche Riunite Angelini Francesco S.p.A | 184 | 2020-06-18 | 2022-03-04 | |
| Efficacy and Safety of Teicoplanin in CDAD TEICOPLANIN - Clostridium Difficile Infection-associated Diarrhea and Colitis | Phase 4 | Terminated | Sanofi | 50 | 2020-05-15 | 2025-09-23 |
| Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection Teicoplanin - Lumbar Spinal Stenosis, Lumbar Disc Herniation | Phase 3 | Unknown | Bezmialem Vakif University | 120 | 2020-04-15 | 2020-04-14 |
| Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. - Cystic Fibrosis | Phase 1 | Completed | Neupharma Srl | 12 | 2019-10-25 | 2020-12-09 |
| Tedizolid Prolonged Treatment for Prosthetic Joint Infections Tedizolid Phosphate 200 MG [Sivextro] - Prosthetic Joint Infection | Not applicable | Completed | Tourcoing Hospital | 35 | 2018-08-28 | 2021-09-08 |
| the Clinical Trial of Teicoplanin for Injection Teicoplanin for Injection - Infectious Disease | Unknown | Jiangsu Famous Medical Technology Co., Ltd. | 100000 | 2017-01-01 | 2017-01-13 | |
| Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) Amoxicillin-clavulanate, Piperacillin-tazobactam, Meropenem - Pharmacokinetics, Amoxicillin-clavulanate | Not applicable | Recruiting | University Hospital, Ghent | 300 | 2016-08-19 | 2026-09-21 |
| PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4 PRF mixed with amikacin and teicoplanin, PRF mixed with PHMB plus Macrogolol, PRF plus normal saline - Chronic Skin Ulcer | Not applicable | Recruiting | Medical University of Vienna | 120 | 2014-06-01 | 2022-04-07 |
| The Amputation Surgical Site Infection Trial (ASSIT) Co-amoxiclav, Iodine, Metronidazole - Wound Infection, Amputation Wound | Phase 4 | Completed | Hull University Teaching Hospitals NHS Trust | 160 | 2013-10-08 | 2019-07-15 |
| Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study teicoplanin - Osteoarticular Infection | Phase 2 | Completed | Centre Hospitalier Universitaire, Amiens | 30 | 2013-03-01 | 2025-09-19 |
| Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation Implemented procedure - Infection of Skin and/or Subcutaneous Tissue | Not applicable | Withdrawn | Federico II University | 2012-03-01 | 2012-12-31 | |
| Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection Vancomycin, Teicoplanin, Linezolid - Neurosurgery | Phase 1 | Withdrawn | Aarhus University Hospital | 2011-09-01 | 2015-01-26 | |
| Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci daptomycin, vancomycin, teicoplanin - Osteomyelitis | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 75 | 2007-06-26 | 2018-01-31 |
| A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely teicoplanin - Staphylococcal Infections | Phase 4 | Unknown | National Taiwan University Hospital | 20 | 2006-06-01 | 2006-08-24 |
| Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections Daptomycin, Vancomycin, Teicoplanin - Skin Diseases, Infectious, Soft Tissue Infections | Phase 3 | Terminated | Novartis Pharmaceuticals | 194 | 2006-04-01 | 2012-07-16 |
| Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients Teicoplanin, Vancomycin - Infection, Febrile Neutropenia | Phase 4 | Completed | Sanofi | 197 | 2005-01-01 | 2009-03-06 |
Showing 20 of 23. Sign in to see all of them.
Infections (4) · Febrile Neutropenia (3) · Cellulitis (2) · Neoplasms (2) · Neutropenia (2) · Surgical Wound Infection (2) · Acute-On-Chronic Liver Failure (1) · Bacterial Infections (1) · Biliary Atresia (1) · Cholangitis (1) · Colitis (1) · Communicable Diseases (1) · Cystic Fibrosis (1) · Fever (1) · Hematologic Neoplasms (1)
Sanofi (2) · Aarhus University Hospital (1) · Aziende Chimiche Riunite Angelini Francesco S.p.A (1) · Bezmialem Vakif University (1) · Centre Hospitalier Universitaire, Amiens (1) · Children's Cancer and Leukaemia Group (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Federico II University (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Hull University Teaching Hospitals NHS Trust (1) · Institute of Liver and Biliary Sciences, India (1) · Jiangsu Famous Medical Technology Co., Ltd. (1) · Medical University of Vienna (1) · National Taiwan University Hospital (1) · Neupharma Srl (1)
Italy (3) · United Kingdom (3) · China (2) · France (2) · Greece (2) · Spain (2) · Austria (1) · Belgium (1) · India (1) · Ireland (1) · Netherlands (1) · Russia (1) · Taiwan (1) · Turkey (Türkiye) (1) · United States (1)
Alistair Wheeler, MD (1) · Amyntas Varvaroussis, MD (1) · Annick de Jaeger, MD (1) · Antonios Papadopoulos, MD, PhD (1) · Barry Pizer, MD (1) · Edibe Taylan (1) · Feng Jiexiong, Postdoctoral (1) · Florian Thalhammer, Prof. Dr. (1) · Giulia Paiola, MD (1) · Guglielmo Borgia (1) · Helen Giamarellou, MD, PhD (1)
PMID 14986270, PMID 15329363, PMID 16982292, PMID 18818959, PMID 20176900, PMID 20675299, PMID 22157324, PMID 22908174, PMID 23926058, PMID 23988422, PMID 25135090, PMID 25139552, PMID 25331703, PMID 25650692, PMID 26232669, PMID 26457865, PMID 26906190, PMID 27317442, PMID 27458228, PMID 35325055, PMID 37678274
2017 (1), 2023 (1)